Are we measuring what truly matters: Health-related quality of life in type 1 diabetes
Journal of Pediatric Endocrinology and Diabetes · 15.04.2026 · 6 · 13-15
DOI: 10.25259/jped_25_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Diabetes, online erschienen am 15.04.2026. Verfasst von Leena Priyambada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Quick Response Code:Health-related quality of life (HRQoL) has increasingly emerged as a critical outcome in the management of chronic conditions.[1] is refers to the impact of a health condition and its treatment on an individual's physical, psychological, and social well-being.Unlike traditional clinical outcomes that focus primarily on physiological parameters, HRQoL captures how the disease affects overall daily functioning and life satisfaction.In type 1 diabetes (T1D), HRQoL is particularly important, as proper management demands continuous attention to every meal, physical activity, illness, and stress, as well as real-time decision-making.[2] is can impose a substantial psychological burden on children and their families.Hence, the success of diabetes management requires consideration not only of glycemic outcomes but also of the lived experience of the disease.[3] T1D TECHNOLOGY AND TREATMENT OUTCOMESOver the past decade, advances in diabetes technology have transformed T1D management.Continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems have improved the precision with which glucose levels can be managed.A large registry involving more than 100,000 children and adolescents with T1D has demonstrated improved glycemic outcomes parallel to increased use of diabetes technology.[4] ere is an assumption that these technologies will improve HRQoL.Many real-world studies also support this expectation.Youth with T1D using the Control-IQ AID system demonstrated improvements in both glycemic outcomes and patient-reported measures, including higher treatment satisfaction and lower perceived diabetes burden.[5] Improvements in glycated hemoglobin, time in range, hypoglycemia as well as reduced fear and worry related to hypoglycemia, and enhanced sleep quality have also been observed even 12-month post-AID adoption.[6] However, these parallel improvements may not always happen.e study by de Almagro et al. in the current issue of the journal provides an opportunity to reflect on this question.[7] During the evaluation of children with T1D treated with either multiple daily injections or AID systems, the authors observed improved glycemic outcomes among those using AID, but HRQoL scores did not differ significantly.A lack of patient-reported outcomes was also noted in 6-13-year olds and in youth using AID in a few studies.[8,9] https://ispae-jped.com/
Zitieren
APA
Priyambada, L. (2026). Are we measuring what truly matters: Health-related quality of life in type 1 diabetes. Journal of Pediatric Endocrinology and Diabetes, 6, 13-15. https://doi.org/10.25259/jped_25_2026
Vancouver
Priyambada L. Are we measuring what truly matters: Health-related quality of life in type 1 diabetes. Journal of Pediatric Endocrinology and Diabetes. 2026;6:13-15. doi:10.25259/jped_25_2026
BibTeX
@article{Priyambada2026,
author = {Priyambada, Leena},
title = {Are we measuring what truly matters: Health-related quality of life in type 1 diabetes},
journal = {Journal of Pediatric Endocrinology and Diabetes},
year = {2026},
volume = {6},
pages = {13--15},
doi = {10.25259/jped_25_2026}
}
EUVIMED